NF-κB and Not the MAPK Signaling Pathway Regulates GADD45β Expression during Acute Inflammation
The GADD45 (growth arrest and DNA damage-inducible) family of genes is involved in the regulation of cell cycle progression and apoptosis. To study signaling pathways affecting GADD45 β expression and to examine systematically in vivo the GADD45 β expression in tissues following various toxic stre...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2005-06, Vol.280 (22), p.21400 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The GADD45 (growth arrest and DNA damage-inducible) family of genes is involved in the regulation of cell cycle progression and apoptosis.
To study signaling pathways affecting GADD45 β expression and to examine systematically in vivo the GADD45 β expression in tissues following various toxic stresses, we created a transgenic mouse by fusing the GADD45 β promoter to firefly luciferase ( Gadd45β-luc ). In vivo GADD45β expression was assessed by measuring the luciferase activity in the Gadd45β-luc transgenic mouse using a non-invasive imaging system (IVIS® Imaging System, Xenogen Corporation). We found that a number
of agents that induce oxidative stress, such as sodium arsenite, CCl4, lipopolysaccharide (LPS), or tumor necrosis factor-α,
are able to induce luciferase expression throughout the entire animal. In liver, spleen, lung, intestine, kidney, and heart,
we observed an induction of luciferase activity after LPS treatment, which correlates with an increase of GADD45 β mRNA in these tissues. Processes that induce DNA damage activate the NF-κB signaling pathway. Several inhibitors of the
NF-κB signaling pathway, including dexamethasone, thalidomide, and a proteasome inhibitor, bortezomib, showed inhibitory effects
on LPS-induced GADD45β expression as indicated by a decrease of the luciferase activity. Northern blot analysis confirmed
a broad inhibitory effect of bortezomib on LPS-induced GADD45β mRNA expression in spleen, lung, and intestine. In liver of
bortezomib-treated mice, we observed a reverse correlation between the luciferase activity and the GADD45 β mRNA level. We speculate that such a discrepancy could be due to severe liver toxicity caused by bortezomib and LPS co-treatment.
MAPK inhibitors had transient and inconsistent effects on LPS-induced luciferase expression. Our data are consistent with
the notion that NF-κB, but not the MAPK signaling pathways, is involved in the in vivo regulation of GADD45 β expression. Thus, NF-κB signaling involves induction of GADD45 β expression, which supports the proposed role of GADD45 β in protecting cells against DNA damaged under various stress conditions. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M411952200 |